Natixis’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-549
| Closed | -$45.9K | – | 1191 |
|
|
2024
Q4 | $45.9K | Sell |
549
-178
| -24% | -$14.9K | ﹤0.01% | 875 |
|
|
2024
Q3 | $53.2K | Sell |
727
-435
| -37% | -$31.8K | ﹤0.01% | 769 |
|
|
2024
Q2 | $79.6K | Sell |
1,162
-2,571
| -69% | -$176K | ﹤0.01% | 737 |
|
|
2024
Q1 | $258K | Buy |
3,733
+2,329
| +166% | +$161K | ﹤0.01% | 672 |
|
|
2023
Q4 | $101K | Sell |
1,404
-74
| -5% | -$5.3K | ﹤0.01% | 753 |
|
|
2023
Q3 | $77K | Sell |
1,478
-14,403
| -91% | -$750K | ﹤0.01% | 789 |
|
|
2023
Q2 | $1.01M | Buy |
+15,881
| New | +$1.01M | 0.01% | 529 |
|